Biotech Acquisition
| General Information | |
| Business: | We intend to focus our search for a target business in the healthcare sector, with a particular focus on life sciences/biotechnology, healthcare information technology, medical technology and technology-enabled healthcare service sectors. (Note: Biotech Acquisition priced its IPO on Jan. 25, 2021, according to the terms in its prospectus: 20 million units at $10 each to raise $200 million.) |
| Industry: | BLANK CHECKS |
| Employees: | 0 |
| Founded: | 2020 |
| Contact Information | |
| Address | 545 West 25th Street, 20th Floor, New York, NY 10001, US |
| Phone Number | (212) 227-1905 |
| Web Address | |
| View Prospectus: | Biotech Acquisition |
| Financial Information | |
| Market Cap | $250mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | BIOTU |
| Exchange | NASDAQ |
| Shares (millions): | 20.0 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $200.0 mil |
| Manager / Joint Managers | Cantor Fitzgerald |
| CO-Managers | - |
| Expected To Trade: | 1/26/2021 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |